Molecular mechanisms of addiction · First-year biology
One pathway, six ways in
Every addictive drug raises dopamine in the nucleus accumbens. They do it by breaking into different stretches of the same pathway. Watch where each one gets in.
The route: five stations
The pink tube is the mesolimbic pathway, drawn inside a real 3D brain. Click a station to see which cases break in there. Drag to rotate, right-drag or Shift-drag to pan, Ctrl + scroll to zoom.
Six cases, side by side
All six panels show the same circuit from the same angle, at the same moment. Only one thing differs in each. Rotate one and they all rotate. Click ⤢ to enlarge a panel and see every part labeled.
Time is slowed about 4 times. The axon terminal is magnified and the axon is shortened. Dopamine levels come from a simple teaching model; the order (amphetamine-type stimulants highest, then cocaine, then nicotine and opioids) follows rat microdialysis studies (Di Chiara and Imperato 1988). "Firing" and "Brake" show each neuron's rate as a percentage of the no-drug panel.
Takeaways
Same finish line
Every case ends the same way: more dopamine reaching receptors in the nucleus accumbens. Drugs that do not do this rarely cause addiction (Nestler 2025).
Two kinds of doors
Station 1 cases (nicotine, opioids, gambling) change how often the dopamine neuron fires. Station 3 and 4 cases (cocaine, methamphetamine) change how long dopamine stays in the synapse, however often the neuron fires (Lüscher and Ungless 2006).
The long-term change is at the finish
With repeated use, station 5 changes: fewer D2 receptors, and ΔFosB builds up and switches genes for weeks. This is part of why tolerance and craving outlast the drug.
Treatments use the same doors
Naloxone pushes opioids off μ-opioid receptors; varenicline partly occupies nicotinic receptors. "Virtually all available treatments for drug addiction act on the initial protein targets" (Nestler and Lüscher 2019).
Sources
- Lüscher C, Ungless MA (2006). The mechanistic classification of addictive drugs. PLoS Medicine 3: e437. Link ↗
- Nestler EJ (2025). The biology of addiction. Science Signaling 18: eadq0031 (table 1 lists each drug's protein target). Link ↗
- Nestler EJ, Lüscher C (2019). The molecular basis of drug addiction: linking epigenetic to synaptic and circuit mechanisms. Neuron 102: 48–59. Link ↗
- Liu X, Wang F, Le Q, Ma L (2023). Cellular and molecular basis of drug addiction: the role of neuronal ensembles in addiction. Current Opinion in Neurobiology 83: 102813. Link ↗
- Johnson SW, North RA (1992). Opioids excite dopamine neurons by hyperpolarization of local interneurons. Journal of Neuroscience 12: 483–488. PubMed ↗
- Mansvelder HD, McGehee DS (2002). Cellular and synaptic mechanisms of nicotine addiction. Journal of Neurobiology 53: 606–617. PubMed ↗
- Sulzer D, Sonders MS, Poulsen NW, Galli A (2005). Mechanisms of neurotransmitter release by amphetamines: a review. Progress in Neurobiology 75: 406–433. PubMed ↗
- Di Chiara G, Imperato A (1988). Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. PNAS 85: 5274–5278. Link ↗
- Fiorillo CD, Tobler PN, Schultz W (2003). Discrete coding of reward probability and uncertainty by dopamine neurons. Science 299: 1898–1902. Link ↗
- U.S. Department of Health and Human Services (2016). Facing Addiction in America: The Surgeon General's Report on Alcohol, Drugs, and Health, chapter 2. Link ↗
- Brain anatomy: BodyParts3D, © The Database Center for Life Science, licensed under CC Attribution 4.0 International.